Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations
Our goal was to determine if clinically relevant concentrations of aqueous extract of cigarette smoke (CSE) have direct deleterious effects on ventricular myocytes during simulated ischemia, and to investigate the mechanisms involved. CSE was prepared with a smoking chamber. Ischemia was simulated b...
Gespeichert in:
Veröffentlicht in: | Toxicology and applied pharmacology 2009-04, Vol.236 (1), p.71-77 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 77 |
---|---|
container_issue | 1 |
container_start_page | 71 |
container_title | Toxicology and applied pharmacology |
container_volume | 236 |
creator | Yamada, Shigeyuki Zhang, Xiu Quan Kadono, Toshie Matsuoka, Nobuhiro Rollins, Douglas Badger, Troy Rodesch, Christopher K. Barry, William H. |
description | Our goal was to determine if clinically relevant concentrations of aqueous extract of cigarette smoke (CSE) have direct deleterious effects on ventricular myocytes during simulated ischemia, and to investigate the mechanisms involved.
CSE was prepared with a smoking chamber. Ischemia was simulated by metabolic inhibition (MI) with cyanide (CN) and 0 glucose. Adult rabbit and mouse ventricular myocyte [Ca
2+]
i was measured by flow cytometry using fluo-3. Mitochondrial [Ca
2+] was measured with confocal microscopy, and Rhod-2 fluorescence. The mitochondrial permeability transition (MPT) was detected by TMRM fluorescence and myocyte contracture. Myocyte oxidative stress was quantified by dichlorofluorescein (DCF) fluorescence with confocal microscopy.
CSE 0.1% increased myocyte contracture caused by MI. The nicotine concentration (HPLC) in 0.1% CSE was 15 ng/ml, similar to that in humans after smoking cigarettes. CSE 0.1% increased mitochondrial Ca
2+ uptake, and increased the susceptibility of mitochondria to the MPT. CSE 0.1% increased DCF fluorescence in isolated myocytes, and increased [Ca
2+]
i in paced myocytes exposed to 2.0 mM CN, 0 glucose (P-MI). These effects were inhibited by the superoxide scavenger Tiron. The effect of CSE on [Ca
2+]
i during P-MI was also prevented by ranolazine.
CSE in clinically relevant concentrations increases myocyte [Ca
2+]
i during simulated ischemia, and increases myocyte susceptibility to the MPT. These effects appear to be mediated at least in part by oxidative radicals in CSE, and likely contribute to the effects of cigarette smoke to increase myocardial infarct size, and to decrease angina threshold. |
doi_str_mv | 10.1016/j.taap.2009.01.008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21182769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X09000283</els_id><sourcerecordid>20433719</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-6b63c102b0e8d425861b3b7ad6d7a2071028bc388f9d5b7980a90f4d8aeb3a373</originalsourceid><addsrcrecordid>eNp9kU-P1DAMxSMEYoeFL8ABRUJw6-Ak3TaVuKDlr7QSF5C4RW7qQoa2GZLMaufb4zIjuHGKYv9s-b0nxFMFWwWqebXbFsT9VgN0W1BbAHtPbBR0TQXGmPtiA1CrisvfLsSjnHfAYF2rh-JCdaZVjVYbUd6GRL7IEu-ClzSO_MkyjhJ_HSgesqS7kpABLvnwHROVQjLP8SfJuEiPaQjo5XyM_lgoSyzST2EJHqfpKBNNdIsL1-LiaeFNJcQlPxYPRpwyPTm_l-Lr-3dfrj9WN58_fLp-c1P5ujalavrGeAW6B7JDra9so3rTtzg0Q4saWm7Z3htrx2646tvOAnYw1oNF6g2a1lyK56e9MZfgsg-F_A8-ZWGRTitlddt0TL08UfsUWXQubg7Z0zThsjrgNNSG7VpBfQJ9ijknGt0-hRnT0SlwayJu59ZE3JqIA-XYeh56dt5-6Gca_o2cI2DgxRnAzK6NCRcf8l9OK911tl251yeO2LHbQGkVRGzr8CdBN8Twvzt-A22nqvQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20433719</pqid></control><display><type>article</type><title>Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yamada, Shigeyuki ; Zhang, Xiu Quan ; Kadono, Toshie ; Matsuoka, Nobuhiro ; Rollins, Douglas ; Badger, Troy ; Rodesch, Christopher K. ; Barry, William H.</creator><creatorcontrib>Yamada, Shigeyuki ; Zhang, Xiu Quan ; Kadono, Toshie ; Matsuoka, Nobuhiro ; Rollins, Douglas ; Badger, Troy ; Rodesch, Christopher K. ; Barry, William H.</creatorcontrib><description>Our goal was to determine if clinically relevant concentrations of aqueous extract of cigarette smoke (CSE) have direct deleterious effects on ventricular myocytes during simulated ischemia, and to investigate the mechanisms involved.
CSE was prepared with a smoking chamber. Ischemia was simulated by metabolic inhibition (MI) with cyanide (CN) and 0 glucose. Adult rabbit and mouse ventricular myocyte [Ca
2+]
i was measured by flow cytometry using fluo-3. Mitochondrial [Ca
2+] was measured with confocal microscopy, and Rhod-2 fluorescence. The mitochondrial permeability transition (MPT) was detected by TMRM fluorescence and myocyte contracture. Myocyte oxidative stress was quantified by dichlorofluorescein (DCF) fluorescence with confocal microscopy.
CSE 0.1% increased myocyte contracture caused by MI. The nicotine concentration (HPLC) in 0.1% CSE was 15 ng/ml, similar to that in humans after smoking cigarettes. CSE 0.1% increased mitochondrial Ca
2+ uptake, and increased the susceptibility of mitochondria to the MPT. CSE 0.1% increased DCF fluorescence in isolated myocytes, and increased [Ca
2+]
i in paced myocytes exposed to 2.0 mM CN, 0 glucose (P-MI). These effects were inhibited by the superoxide scavenger Tiron. The effect of CSE on [Ca
2+]
i during P-MI was also prevented by ranolazine.
CSE in clinically relevant concentrations increases myocyte [Ca
2+]
i during simulated ischemia, and increases myocyte susceptibility to the MPT. These effects appear to be mediated at least in part by oxidative radicals in CSE, and likely contribute to the effects of cigarette smoke to increase myocardial infarct size, and to decrease angina threshold.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/j.taap.2009.01.008</identifier><identifier>PMID: 19371621</identifier><identifier>CODEN: TXAPA9</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt - pharmacology ; 60 APPLIED LIFE SCIENCES ; Acetanilides - pharmacology ; Angina Pectoris - etiology ; Angina Pectoris - metabolism ; Animals ; Biological and medical sciences ; CALCIUM ; Calcium - metabolism ; CALCIUM IONS ; CARBON NITRIDES ; Cells, Cultured ; Cigarette smoke ; CYANIDES ; Dose-Response Relationship, Drug ; Enzyme Inhibitors - pharmacology ; FLUORESCENCE ; Free Radical Scavengers - pharmacology ; GLUCOSE ; Glucose - metabolism ; Heart Ventricles - drug effects ; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY ; ISCHEMIA ; Medical sciences ; MICE ; MITOCHONDRIA ; Mitochondria, Heart - drug effects ; Mitochondria, Heart - metabolism ; Mitochondrial Membrane Transport Proteins - drug effects ; Mitochondrial Membrane Transport Proteins - metabolism ; Myocardial Contraction - drug effects ; Myocardial Infarction - etiology ; Myocardial Infarction - physiopathology ; Myocardial Ischemia - complications ; Myocardial Ischemia - metabolism ; Myocardial Ischemia - physiopathology ; Myocyte ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; NICOTINE ; Nicotine - analysis ; OXIDATION ; Piperazines - pharmacology ; RABBITS ; Ranolazine ; Reactive Oxygen Species - metabolism ; Smoke - adverse effects ; Smoke - analysis ; Smoking - adverse effects ; Time Factors ; TIRON ; TOBACCO SMOKES ; Tobacco, tobacco smoking ; TOXICITY ; Toxicology</subject><ispartof>Toxicology and applied pharmacology, 2009-04, Vol.236 (1), p.71-77</ispartof><rights>2009 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-6b63c102b0e8d425861b3b7ad6d7a2071028bc388f9d5b7980a90f4d8aeb3a373</citedby><cites>FETCH-LOGICAL-c443t-6b63c102b0e8d425861b3b7ad6d7a2071028bc388f9d5b7980a90f4d8aeb3a373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041008X09000283$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21299871$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19371621$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21182769$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Shigeyuki</creatorcontrib><creatorcontrib>Zhang, Xiu Quan</creatorcontrib><creatorcontrib>Kadono, Toshie</creatorcontrib><creatorcontrib>Matsuoka, Nobuhiro</creatorcontrib><creatorcontrib>Rollins, Douglas</creatorcontrib><creatorcontrib>Badger, Troy</creatorcontrib><creatorcontrib>Rodesch, Christopher K.</creatorcontrib><creatorcontrib>Barry, William H.</creatorcontrib><title>Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>Our goal was to determine if clinically relevant concentrations of aqueous extract of cigarette smoke (CSE) have direct deleterious effects on ventricular myocytes during simulated ischemia, and to investigate the mechanisms involved.
CSE was prepared with a smoking chamber. Ischemia was simulated by metabolic inhibition (MI) with cyanide (CN) and 0 glucose. Adult rabbit and mouse ventricular myocyte [Ca
2+]
i was measured by flow cytometry using fluo-3. Mitochondrial [Ca
2+] was measured with confocal microscopy, and Rhod-2 fluorescence. The mitochondrial permeability transition (MPT) was detected by TMRM fluorescence and myocyte contracture. Myocyte oxidative stress was quantified by dichlorofluorescein (DCF) fluorescence with confocal microscopy.
CSE 0.1% increased myocyte contracture caused by MI. The nicotine concentration (HPLC) in 0.1% CSE was 15 ng/ml, similar to that in humans after smoking cigarettes. CSE 0.1% increased mitochondrial Ca
2+ uptake, and increased the susceptibility of mitochondria to the MPT. CSE 0.1% increased DCF fluorescence in isolated myocytes, and increased [Ca
2+]
i in paced myocytes exposed to 2.0 mM CN, 0 glucose (P-MI). These effects were inhibited by the superoxide scavenger Tiron. The effect of CSE on [Ca
2+]
i during P-MI was also prevented by ranolazine.
CSE in clinically relevant concentrations increases myocyte [Ca
2+]
i during simulated ischemia, and increases myocyte susceptibility to the MPT. These effects appear to be mediated at least in part by oxidative radicals in CSE, and likely contribute to the effects of cigarette smoke to increase myocardial infarct size, and to decrease angina threshold.</description><subject>1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt - pharmacology</subject><subject>60 APPLIED LIFE SCIENCES</subject><subject>Acetanilides - pharmacology</subject><subject>Angina Pectoris - etiology</subject><subject>Angina Pectoris - metabolism</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>CALCIUM</subject><subject>Calcium - metabolism</subject><subject>CALCIUM IONS</subject><subject>CARBON NITRIDES</subject><subject>Cells, Cultured</subject><subject>Cigarette smoke</subject><subject>CYANIDES</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>FLUORESCENCE</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>GLUCOSE</subject><subject>Glucose - metabolism</subject><subject>Heart Ventricles - drug effects</subject><subject>HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY</subject><subject>ISCHEMIA</subject><subject>Medical sciences</subject><subject>MICE</subject><subject>MITOCHONDRIA</subject><subject>Mitochondria, Heart - drug effects</subject><subject>Mitochondria, Heart - metabolism</subject><subject>Mitochondrial Membrane Transport Proteins - drug effects</subject><subject>Mitochondrial Membrane Transport Proteins - metabolism</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocardial Infarction - etiology</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Ischemia - complications</subject><subject>Myocardial Ischemia - metabolism</subject><subject>Myocardial Ischemia - physiopathology</subject><subject>Myocyte</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>NICOTINE</subject><subject>Nicotine - analysis</subject><subject>OXIDATION</subject><subject>Piperazines - pharmacology</subject><subject>RABBITS</subject><subject>Ranolazine</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Smoke - adverse effects</subject><subject>Smoke - analysis</subject><subject>Smoking - adverse effects</subject><subject>Time Factors</subject><subject>TIRON</subject><subject>TOBACCO SMOKES</subject><subject>Tobacco, tobacco smoking</subject><subject>TOXICITY</subject><subject>Toxicology</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU-P1DAMxSMEYoeFL8ABRUJw6-Ak3TaVuKDlr7QSF5C4RW7qQoa2GZLMaufb4zIjuHGKYv9s-b0nxFMFWwWqebXbFsT9VgN0W1BbAHtPbBR0TQXGmPtiA1CrisvfLsSjnHfAYF2rh-JCdaZVjVYbUd6GRL7IEu-ClzSO_MkyjhJ_HSgesqS7kpABLvnwHROVQjLP8SfJuEiPaQjo5XyM_lgoSyzST2EJHqfpKBNNdIsL1-LiaeFNJcQlPxYPRpwyPTm_l-Lr-3dfrj9WN58_fLp-c1P5ujalavrGeAW6B7JDra9so3rTtzg0Q4saWm7Z3htrx2646tvOAnYw1oNF6g2a1lyK56e9MZfgsg-F_A8-ZWGRTitlddt0TL08UfsUWXQubg7Z0zThsjrgNNSG7VpBfQJ9ijknGt0-hRnT0SlwayJu59ZE3JqIA-XYeh56dt5-6Gca_o2cI2DgxRnAzK6NCRcf8l9OK911tl251yeO2LHbQGkVRGzr8CdBN8Twvzt-A22nqvQ</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Yamada, Shigeyuki</creator><creator>Zhang, Xiu Quan</creator><creator>Kadono, Toshie</creator><creator>Matsuoka, Nobuhiro</creator><creator>Rollins, Douglas</creator><creator>Badger, Troy</creator><creator>Rodesch, Christopher K.</creator><creator>Barry, William H.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7U7</scope><scope>C1K</scope><scope>OTOTI</scope></search><sort><creationdate>20090401</creationdate><title>Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations</title><author>Yamada, Shigeyuki ; Zhang, Xiu Quan ; Kadono, Toshie ; Matsuoka, Nobuhiro ; Rollins, Douglas ; Badger, Troy ; Rodesch, Christopher K. ; Barry, William H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-6b63c102b0e8d425861b3b7ad6d7a2071028bc388f9d5b7980a90f4d8aeb3a373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt - pharmacology</topic><topic>60 APPLIED LIFE SCIENCES</topic><topic>Acetanilides - pharmacology</topic><topic>Angina Pectoris - etiology</topic><topic>Angina Pectoris - metabolism</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>CALCIUM</topic><topic>Calcium - metabolism</topic><topic>CALCIUM IONS</topic><topic>CARBON NITRIDES</topic><topic>Cells, Cultured</topic><topic>Cigarette smoke</topic><topic>CYANIDES</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>FLUORESCENCE</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>GLUCOSE</topic><topic>Glucose - metabolism</topic><topic>Heart Ventricles - drug effects</topic><topic>HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY</topic><topic>ISCHEMIA</topic><topic>Medical sciences</topic><topic>MICE</topic><topic>MITOCHONDRIA</topic><topic>Mitochondria, Heart - drug effects</topic><topic>Mitochondria, Heart - metabolism</topic><topic>Mitochondrial Membrane Transport Proteins - drug effects</topic><topic>Mitochondrial Membrane Transport Proteins - metabolism</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocardial Infarction - etiology</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Ischemia - complications</topic><topic>Myocardial Ischemia - metabolism</topic><topic>Myocardial Ischemia - physiopathology</topic><topic>Myocyte</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>NICOTINE</topic><topic>Nicotine - analysis</topic><topic>OXIDATION</topic><topic>Piperazines - pharmacology</topic><topic>RABBITS</topic><topic>Ranolazine</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Smoke - adverse effects</topic><topic>Smoke - analysis</topic><topic>Smoking - adverse effects</topic><topic>Time Factors</topic><topic>TIRON</topic><topic>TOBACCO SMOKES</topic><topic>Tobacco, tobacco smoking</topic><topic>TOXICITY</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Shigeyuki</creatorcontrib><creatorcontrib>Zhang, Xiu Quan</creatorcontrib><creatorcontrib>Kadono, Toshie</creatorcontrib><creatorcontrib>Matsuoka, Nobuhiro</creatorcontrib><creatorcontrib>Rollins, Douglas</creatorcontrib><creatorcontrib>Badger, Troy</creatorcontrib><creatorcontrib>Rodesch, Christopher K.</creatorcontrib><creatorcontrib>Barry, William H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>OSTI.GOV</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Shigeyuki</au><au>Zhang, Xiu Quan</au><au>Kadono, Toshie</au><au>Matsuoka, Nobuhiro</au><au>Rollins, Douglas</au><au>Badger, Troy</au><au>Rodesch, Christopher K.</au><au>Barry, William H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>236</volume><issue>1</issue><spage>71</spage><epage>77</epage><pages>71-77</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><coden>TXAPA9</coden><abstract>Our goal was to determine if clinically relevant concentrations of aqueous extract of cigarette smoke (CSE) have direct deleterious effects on ventricular myocytes during simulated ischemia, and to investigate the mechanisms involved.
CSE was prepared with a smoking chamber. Ischemia was simulated by metabolic inhibition (MI) with cyanide (CN) and 0 glucose. Adult rabbit and mouse ventricular myocyte [Ca
2+]
i was measured by flow cytometry using fluo-3. Mitochondrial [Ca
2+] was measured with confocal microscopy, and Rhod-2 fluorescence. The mitochondrial permeability transition (MPT) was detected by TMRM fluorescence and myocyte contracture. Myocyte oxidative stress was quantified by dichlorofluorescein (DCF) fluorescence with confocal microscopy.
CSE 0.1% increased myocyte contracture caused by MI. The nicotine concentration (HPLC) in 0.1% CSE was 15 ng/ml, similar to that in humans after smoking cigarettes. CSE 0.1% increased mitochondrial Ca
2+ uptake, and increased the susceptibility of mitochondria to the MPT. CSE 0.1% increased DCF fluorescence in isolated myocytes, and increased [Ca
2+]
i in paced myocytes exposed to 2.0 mM CN, 0 glucose (P-MI). These effects were inhibited by the superoxide scavenger Tiron. The effect of CSE on [Ca
2+]
i during P-MI was also prevented by ranolazine.
CSE in clinically relevant concentrations increases myocyte [Ca
2+]
i during simulated ischemia, and increases myocyte susceptibility to the MPT. These effects appear to be mediated at least in part by oxidative radicals in CSE, and likely contribute to the effects of cigarette smoke to increase myocardial infarct size, and to decrease angina threshold.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>19371621</pmid><doi>10.1016/j.taap.2009.01.008</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-008X |
ispartof | Toxicology and applied pharmacology, 2009-04, Vol.236 (1), p.71-77 |
issn | 0041-008X 1096-0333 |
language | eng |
recordid | cdi_osti_scitechconnect_21182769 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt - pharmacology 60 APPLIED LIFE SCIENCES Acetanilides - pharmacology Angina Pectoris - etiology Angina Pectoris - metabolism Animals Biological and medical sciences CALCIUM Calcium - metabolism CALCIUM IONS CARBON NITRIDES Cells, Cultured Cigarette smoke CYANIDES Dose-Response Relationship, Drug Enzyme Inhibitors - pharmacology FLUORESCENCE Free Radical Scavengers - pharmacology GLUCOSE Glucose - metabolism Heart Ventricles - drug effects HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY ISCHEMIA Medical sciences MICE MITOCHONDRIA Mitochondria, Heart - drug effects Mitochondria, Heart - metabolism Mitochondrial Membrane Transport Proteins - drug effects Mitochondrial Membrane Transport Proteins - metabolism Myocardial Contraction - drug effects Myocardial Infarction - etiology Myocardial Infarction - physiopathology Myocardial Ischemia - complications Myocardial Ischemia - metabolism Myocardial Ischemia - physiopathology Myocyte Myocytes, Cardiac - drug effects Myocytes, Cardiac - metabolism NICOTINE Nicotine - analysis OXIDATION Piperazines - pharmacology RABBITS Ranolazine Reactive Oxygen Species - metabolism Smoke - adverse effects Smoke - analysis Smoking - adverse effects Time Factors TIRON TOBACCO SMOKES Tobacco, tobacco smoking TOXICITY Toxicology |
title | Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T03%3A54%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20toxic%20effects%20of%20aqueous%20extract%20of%20cigarette%20smoke%20on%20cardiac%20myocytes%20at%20clinically%20relevant%20concentrations&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Yamada,%20Shigeyuki&rft.date=2009-04-01&rft.volume=236&rft.issue=1&rft.spage=71&rft.epage=77&rft.pages=71-77&rft.issn=0041-008X&rft.eissn=1096-0333&rft.coden=TXAPA9&rft_id=info:doi/10.1016/j.taap.2009.01.008&rft_dat=%3Cproquest_osti_%3E20433719%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20433719&rft_id=info:pmid/19371621&rft_els_id=S0041008X09000283&rfr_iscdi=true |